Liyu Liu
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
LMP1 Activates the Wnt/β-Catenin Signaling Pathway and Promotes Nasopharyngeal Carcinoma Progression Through Its Interaction With DVL2.
Journal: Journal of medical virology
Published: December 22, 2025
Immunotherapy rechallenge in Extensive-Stage small cell lung Cancer: A Real-World retrospective study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 22, 2025
Sugemalimab for Post-PD-1 Progression in Non-small Cell Lung Cancer.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: July 08, 2025
Potential biomarkers of primary resistance to first- and second-generation EGFR-TKIs in non-small-cell lung cancer: a real-world study.
Journal: Therapeutic advances in medical oncology
Published: December 08, 2024
Single-cell transcriptome analysis reveals the malignant characteristics of tumour cells and the immunosuppressive landscape in HER2-positive inflammatory breast cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: November 06, 2024
Anlotinib plus docetaxel vs. docetaxel alone for advanced non-small-cell lung cancer patients who failed first-line treatment: A multicenter, randomized phase II trial.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 15, 2024
Influence factors of the survival in colorectal cancer patients with second primary malignancy after surgery: A SEER database analysis.
Journal: Medicine
Published: October 06, 2023
A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancer.
Journal: British journal of cancer
Published: April 10, 2023
Rh-endostatin plus camrelizumab and chemotherapy in first-line treatment of advanced non-small cell lung cancer: A multicenter retrospective study.
Journal: Cancer medicine
Published: October 03, 2022
The efficacy and safety of immune checkpoint inhibitors combined with chemotherapy or anti-angiogenic therapy as a second-line or later treatment option for advanced non-small cell lung cancer: a retrospective comparative cohort study.
Journal: Translational lung cancer research
Published: July 16, 2022
Perivascular epithelioid cell tumor of the lung: A case report and literature review.
Journal: Thoracic cancer
Published: June 25, 2022
Last Updated: 09/26/2026